BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q3 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,585,000 | +58.8% | 58,300 | +70.4% | 0.06% | +84.8% |
| Q3 2016 | $1,628,000 | -41.2% | 34,208 | -44.1% | 0.03% | -31.2% |
| Q2 2016 | $2,768,000 | -51.3% | 61,208 | -55.7% | 0.05% | -52.0% |
| Q1 2016 | $5,682,000 | +339.8% | 138,290 | +308.0% | 0.10% | +614.3% |
| Q4 2015 | $1,292,000 | -38.4% | 33,891 | -46.9% | 0.01% | -30.0% |
| Q3 2015 | $2,096,000 | -72.3% | 63,788 | -41.0% | 0.02% | -71.0% |
| Q2 2015 | $7,564,000 | -1.0% | 108,159 | -3.0% | 0.07% | -9.2% |
| Q1 2015 | $7,638,000 | -49.5% | 111,505 | -45.9% | 0.08% | -19.1% |
| Q4 2014 | $15,117,000 | -46.0% | 206,263 | -47.1% | 0.09% | -32.4% |
| Q3 2014 | $27,971,000 | -5.2% | 389,737 | -4.5% | 0.14% | -1.4% |
| Q2 2014 | $29,520,000 | -16.7% | 408,300 | -15.2% | 0.14% | -28.8% |
| Q1 2014 | $35,429,000 | +82.2% | 481,500 | +72.2% | 0.20% | +90.4% |
| Q4 2013 | $19,446,000 | +48.5% | 279,594 | +40.3% | 0.10% | +28.4% |
| Q3 2013 | $13,094,000 | +42.5% | 199,331 | +50.3% | 0.08% | +44.6% |
| Q2 2013 | $9,187,000 | – | 132,617 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |